Professor Paul Turner
Microbiology in the tropics
Infectious diseases are prevalent in Cambodia, a country that is struggling with poor infrastructure. Streptococcus pneumoniae causes the most severe form of pneumonia and is now targeted by the pneumococcal conjugate vaccine. Dr Paul Turner is studying the effect of this vaccine in field conditions in SE Asia, as well as other direct applications such as the evaluation of a new diagnostic test for Typhoid and interventions to reduce the burden of infections acquired within hospitals.
MB BS, PhD, FRCPCH, FRCPath
Professor of Paediatric Microbiology
- Senior Clinical Research Fellow
- Consultant in Microbiology
- Director of the Cambodia Oxford Medical Research Unit
- Principal Investigator for the ACORN Clinical AMR Surveillance Network
Clinical microbiologist with a focus on paediatric infections
Paul Turner is based at the Cambodia-Oxford Medical Research Unit (COMRU), Angkor Hospital for Children in Siem Reap, Cambodia.
He co-leads the ACORN clinical AMR surveillance network with OUCRU-Hanoi's Rogier van Doorn.
His research interests include:
- Antimicrobial resistance surveillance and control;
- Paediatric healthcare associated infections;
- Pneumococcal colonisation and disease and the impact of pneumococcal vaccines;
- Utilisation of bacterial colonisation data.
His non-research work focuses on development of human and laboratory capacity for diagnostic microbiology in low-resource settings, with a focus on improving laboratory informatics.
Chandna A. et al, (2023), Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Chandna A. et al, (2023), Scientific reports, 13
Carey ME. et al, (2023), eLife, 12
Mo Y. et al, (2023), Wellcome Open Research, 8, 179 - 179
GBD 2019 Meningitis Antimicrobial Resistance Collaborators None., (2023), The Lancet. Neurology, 22, 685 - 711